NCT04000061 Heart Failure-USB: Prediction and Progression
| NCT ID | NCT04000061 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Basel, Switzerland |
| Condition | Acute Heart Failure |
| Study Type | OBSERVATIONAL |
| Enrollment | 6,000 participants |
| Start Date | 2019-06-13 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 6,000 participants in total. It began in 2019-06-13 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This retrospective cohort study is to identify triggers of heart failure (HF) development and drivers of HF progression as well as the underlying cardiac disease (phenotype) to identify patients at risk and predict the clinical course of the disease. Data of patients who were hospitalized during the years 2010-2023 with acute coronary syndrome (ACS) and/ or with acute heart failure (AHF) will be collected and analyzed. In a subgroup cohort efficacy and safety of digoxin in patients with acute heart failure triggered by tachyarrhythmia will be evaluated.
Eligibility Criteria
Inclusion Criteria: * Patients hospitalized with a primary diagnosis of ACS * Patients hospitalized with a primary or secondary diagnosis of AHF Exclusion Criteria: * Existence of a documented statement of the patient against the scientific use of clinical data
Contact & Investigator
Christian Müller, Prof. Dr.
PRINCIPAL INVESTIGATOR
Cardiology University Hospital Basel
Frequently Asked Questions
Who can join the NCT04000061 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Heart Failure. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04000061 currently recruiting?
Yes, NCT04000061 is actively recruiting participants. Contact the research team at Christian.mueller@usb.ch for enrollment information.
Where is the NCT04000061 trial being conducted?
This trial is being conducted at Basel, Switzerland.
Who is sponsoring the NCT04000061 clinical trial?
NCT04000061 is sponsored by University Hospital, Basel, Switzerland. The principal investigator is Christian Müller, Prof. Dr. at Cardiology University Hospital Basel. The trial plans to enroll 6,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.